Last 12 months
Inside the activity.
1 purchase rows · 37 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 9 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 8 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2020 Filed Mar 4, 2020 21:16 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 7,260 | $124.32 | $902,563.20 |
DisclosureSEC source: 0001179110-20-003059 · edgar.xml · nonDerivative · entry 4 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 655,398 F2 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:16 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 13,946 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-20-003059 · edgar.xml · nonDerivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 662,658 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:16 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 6,492 | $124.32 | $807,085.44 |
DisclosureSEC source: 0001179110-20-003059 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 648,712 F2 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:16 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 13,280 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-20-003059 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 655,204 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 16:30 UTC |
Turitz AndrewSVP - Business Development
|
GrantPerformance Stock Units · Derivative | 7,699 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-002586 · edgar.xml · derivative · entry 1 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,699 Underlying: Common Stock · 7,699 shares Expires not disclosed F1 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F2 · shares: Performance award amount determined based on metrics in respect of the issuer's 2019 financial results. F3 · derivative.exercise_date: The performance stock unit vests in three equal annual installments beginning March 4, 2020. F3 · derivative.expiration_date: The performance stock unit vests in three equal annual installments beginning March 4, 2020. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 16:31 UTC |
Verstraete StephanyChief Marketing Officer
|
GrantPerformance Stock Units · Derivative | 14,434 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-002592 · edgar.xml · derivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,434 Underlying: Common stock · 14,434 shares Expires not disclosed F1 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F2 · shares: Performance award amount determined based on metrics in respect of the issuer's 2019 financial results. F3 · derivative.exercise_date: The performance stock unit vests in three equal annual installments beginning March 4, 2020. F3 · derivative.expiration_date: The performance stock unit vests in three equal annual installments beginning March 4, 2020. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 21:31 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
GrantPerformance Stock Units · Derivative | 13,472 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-002590 · edgar.xml · derivative · entry 1 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,472 Underlying: Common Stock · 13,472 shares Expires not disclosed F1 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F2 · shares: Performance award amount determined based on metrics in respect of the issuer's 2019 financial results. F3 · derivative.exercise_date: The performance stock unit vests in three equal annual installments beginning March 4, 2020. F3 · derivative.expiration_date: The performance stock unit vests in three equal annual installments beginning March 4, 2020. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 21:29 UTC |
Levy LewisChief Medical Officer
|
GrantPerformance Stock Units · Derivative | 9,623 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-002584 · edgar.xml · derivative · entry 1 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,623 Underlying: Common Stock · 9,623 shares Expires not disclosed F1 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F2 · shares: Performance award amount determined based on metrics in respect of the issuer's 2019 financial results. F3 · derivative.exercise_date: The performance stock unit vests in three equal annual installments beginning March 4, 2020. F3 · derivative.expiration_date: The performance stock unit vests in three equal annual installments beginning March 4, 2020. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 21:29 UTC |
Bucaria MichelleChief Human Resources Officer
|
GrantPerformance Stock Units · Derivative | 6,735 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-002582 · edgar.xml · derivative · entry 1 Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,735 Underlying: Common Stock · 6,735 shares Expires not disclosed F1 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F2 · shares: Performance award amount determined based on metrics in respect of the issuer's 2019 financial results. F3 · derivative.exercise_date: The performance stock unit vests in three equal annual installments beginning March 4, 2020. F3 · derivative.expiration_date: The performance stock unit vests in three equal annual installments beginning March 4, 2020. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 21:28 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
GrantPerformance Stock Units · Derivative | 65,433 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-002580 · edgar.xml · derivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,433 Underlying: Common Stock · 65,433 shares Expires not disclosed F1 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F2 · shares: Performance award amount determined based on metrics in respect of the issuer's 2019 financial results. F3 · derivative.exercise_date: The performance stock unit vests in three equal annual installments beginning March 4, 2020. F3 · derivative.expiration_date: The performance stock unit vests in three equal annual installments beginning March 4, 2020. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:11 UTC |
Bucaria MichelleChief Human Resources Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,986 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-002209 · edgar.xml · derivative · entry 3 Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,987 Underlying: Common Stock · 1,986 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On February 20, 2018, the reporting person was granted 5,960 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On February 20, 2018, the reporting person was granted 5,960 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:11 UTC |
Bucaria MichelleChief Human Resources Officer
|
Tax withholdingCommon Stock | 774 | $112.89 | $87,376.86 |
DisclosureSEC source: 0001179110-20-002209 · edgar.xml · nonDerivative · entry 2 Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,861 F2 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:11 UTC |
Bucaria MichelleChief Human Resources Officer
|
Exercise / conversionCommon Stock | 1,986 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-20-002209 · edgar.xml · nonDerivative · entry 1 Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,635 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:09 UTC |
Murthy MalaChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 7,968 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-002205 · edgar.xml · derivative · entry 3 Murthy Mala · CIK 0001780955 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,904 Underlying: Common Stock · 7,968 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On June 24, 2019, the reporting person was granted 31,872 restricted stock units, vesting as to 25% of the shares on February 20, 2020 with the remainder of the shares vesting in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On June 24, 2019, the reporting person was granted 31,872 restricted stock units, vesting as to 25% of the shares on February 20, 2020 with the remainder of the shares vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:09 UTC |
Murthy MalaChief Financial Officer
|
Tax withholdingCommon Stock | 2,967 | $112.89 | $334,944.63 |
DisclosureSEC source: 0001179110-20-002205 · edgar.xml · nonDerivative · entry 2 Murthy Mala · CIK 0001780955 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,001 F2 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:09 UTC |
Murthy MalaChief Financial Officer
|
Exercise / conversionCommon Stock | 7,968 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-20-002205 · edgar.xml · nonDerivative · entry 1 Murthy Mala · CIK 0001780955 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,968 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 21:02 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 750 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-20-001133 · edgar.xml · derivative · entry 5 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,750 Underlying: Common Stock · 750 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 21:02 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,275 | $0.00 Strike: $35.45 | $0.00 |
DisclosureSEC source: 0001179110-20-001133 · edgar.xml · derivative · entry 4 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,228 Underlying: Common Stock · 1,275 shares Expires 2027-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on July 14, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 21:02 UTC |
Levy LewisChief Medical Officer
|
SaleCommon Stock | 2,025 | $102.69 | $207,947.25 |
DisclosureSEC source: 0001179110-20-001133 · edgar.xml · nonDerivative · entry 3 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,380 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2019. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 21:02 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionCommon Stock | 750 | $38.55 | $28,912.50 |
DisclosureSEC source: 0001179110-20-001133 · edgar.xml · nonDerivative · entry 2 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,405 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 21:02 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionCommon Stock | 1,275 | $35.45 | $45,198.75 |
DisclosureSEC source: 0001179110-20-001133 · edgar.xml · nonDerivative · entry 1 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,655 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:00 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 750 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-20-000283 · edgar.xml · derivative · entry 5 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,500 Underlying: Common Stock · 750 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:00 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,275 | $0.00 Strike: $35.45 | $0.00 |
DisclosureSEC source: 0001179110-20-000283 · edgar.xml · derivative · entry 4 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,503 Underlying: Common Stock · 1,275 shares Expires 2027-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on July 14, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:00 UTC |
Levy LewisChief Medical Officer
|
SaleCommon Stock | 2,025 | $84.00 | $170,100.00 |
DisclosureSEC source: 0001179110-20-000283 · edgar.xml · nonDerivative · entry 3 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,380 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2019. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:00 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionCommon Stock | 750 | $38.55 | $28,912.50 |
DisclosureSEC source: 0001179110-20-000283 · edgar.xml · nonDerivative · entry 2 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,405 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:00 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionCommon Stock | 1,275 | $35.45 | $45,198.75 |
DisclosureSEC source: 0001179110-20-000283 · edgar.xml · nonDerivative · entry 1 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,655 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 26, 2019 Filed Feb 12, 2020 21:25 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
GiftCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-001513 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 641,924 Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 16:10 UTC |
Turitz AndrewSVP - Business Development
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,150 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-19-012586 · edgar.xml · derivative · entry 7 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,350 Underlying: Common Stock · 2,150 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 16:10 UTC |
Turitz AndrewSVP - Business Development
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,168 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-19-012586 · edgar.xml · derivative · entry 6 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,836 Underlying: Common Stock · 4,168 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 16:10 UTC |
Turitz AndrewSVP - Business Development
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,840 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001179110-19-012586 · edgar.xml · derivative · entry 5 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,841 Underlying: Common Stock · 2,840 shares Expires 2026-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 16:10 UTC |
Turitz AndrewSVP - Business Development
|
SaleCommon Stock | 9,158 | $80.00 | $732,640.00 |
DisclosureSEC source: 0001179110-19-012586 · edgar.xml · nonDerivative · entry 4 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,986 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2019. F2 · price: Represents the weighted average price of transactions ranging from $79.87 to $80.25. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 16:10 UTC |
Turitz AndrewSVP - Business Development
|
Exercise / conversionCommon Stock | 2,150 | $38.55 | $82,882.50 |
DisclosureSEC source: 0001179110-19-012586 · edgar.xml · nonDerivative · entry 3 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,144 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 16:10 UTC |
Turitz AndrewSVP - Business Development
|
Exercise / conversionCommon Stock | 4,168 | $22.30 | $92,946.40 |
DisclosureSEC source: 0001179110-19-012586 · edgar.xml · nonDerivative · entry 2 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,994 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 16:10 UTC |
Turitz AndrewSVP - Business Development
|
Exercise / conversionCommon Stock | 2,840 | $12.21 | $34,676.40 |
DisclosureSEC source: 0001179110-19-012586 · edgar.xml · nonDerivative · entry 1 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,826 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 21:13 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,164 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-19-012587 · edgar.xml · derivative · entry 7 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,444 Underlying: Common Stock · 1,164 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 21:13 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,447 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-19-012587 · edgar.xml · derivative · entry 6 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,147 Underlying: Common Stock · 1,447 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 21:13 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 913 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001179110-19-012587 · edgar.xml · derivative · entry 5 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,741 Underlying: Common Stock · 913 shares Expires 2026-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 21:13 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
SaleCommon Stock | 3,524 | $80.04 | $282,060.96 |
DisclosureSEC source: 0001179110-19-012587 · edgar.xml · nonDerivative · entry 4 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2019. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 21:13 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 1,164 | $38.55 | $44,872.20 |
DisclosureSEC source: 0001179110-19-012587 · edgar.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,724 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 21:13 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 1,447 | $22.30 | $32,268.10 |
DisclosureSEC source: 0001179110-19-012587 · edgar.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,560 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 21:13 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 913 | $12.21 | $11,147.73 |
DisclosureSEC source: 0001179110-19-012587 · edgar.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,113 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 21:06 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 750 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-19-012320 · edgar.xml · derivative · entry 5 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,250 Underlying: Common Stock · 750 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 21:06 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,275 | $0.00 Strike: $35.45 | $0.00 |
DisclosureSEC source: 0001179110-19-012320 · edgar.xml · derivative · entry 4 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,778 Underlying: Common Stock · 1,275 shares Expires 2027-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on July 14, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 21:06 UTC |
Levy LewisChief Medical Officer
|
SaleCommon Stock | 2,025 | $80.50 | $163,012.50 |
DisclosureSEC source: 0001179110-19-012320 · edgar.xml · nonDerivative · entry 3 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,380 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2019. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 21:06 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionCommon Stock | 750 | $38.55 | $28,912.50 |
DisclosureSEC source: 0001179110-19-012320 · edgar.xml · nonDerivative · entry 2 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,405 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 21:06 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionCommon Stock | 1,275 | $35.45 | $45,198.75 |
DisclosureSEC source: 0001179110-19-012320 · edgar.xml · nonDerivative · entry 1 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,655 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 21:01 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,165 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-19-011611 · edgar.xml · derivative · entry 7 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,608 Underlying: Common Stock · 1,165 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 21:01 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,446 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-19-011611 · edgar.xml · derivative · entry 6 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,594 Underlying: Common Stock · 1,446 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 21:01 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 914 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001179110-19-011611 · edgar.xml · derivative · entry 5 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,654 Underlying: Common Stock · 914 shares Expires 2026-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 21:01 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
SaleCommon Stock | 3,525 | $79.12 | $278,898.00 |
DisclosureSEC source: 0001179110-19-011611 · edgar.xml · nonDerivative · entry 4 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 5, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.